Provide you with the best solution for the use of raw materials
Alzheimer's disease (AD) is a progressive neurodegenerative disease with insidious onset. Clinically, it is characterized by generalized dementia, such as memory impairment, aphasia, apraxia, agnosia, impairment of visuospatial skills, executive dysfunction, and personality and behavioral changes. The etiology is still unknown. Those with onset before the age of 65 are called Alzheimer's disease. Those with onset after the age of 65 are called senile dementia.
β-amyloid protein, with a molecular weight of about 4 kDa, is produced by the hydrolysis of β-amyloid precursor protein (APP), which is secreted by cells and has a strong neurotoxic effect after precipitation and accumulation in the cell matrix.
| Cat.No. | Product Name | Application-Platform | Product Description |
|---|---|---|---|
| HA150-1H | Abeta Antibody | Detection-CLIA | Humanized Antibody, a.a.r. 1-7 |
| HA150-2M | Abeta Antibody | Capture-CLIA | Mouse Antibody, a.a.r. 33-42 |
| HA150-3M | Abeta Antibody | Capture-CLIA | Mouse Antibody, a.a.r. 32-40 |
The microtubule system is a component of the neural cytoskeleton and can be involved in a variety of cellular functions. Microtubules are composed of microtubule proteins and microtubule-associated proteins, and Tau protein is the most abundant microtubule-associated protein.
| Cat.No. | Product Name | Application-Platform | Product Description |
|---|---|---|---|
| HA151-1M | Tau Antibody | Detection-CLIA | Mouse Antibody, total Tau, a.a.r. 16-26 |
| HA151-2M | Tau Antibody | Capture-CLIA | Mouse Antibody, total Tau, a.a.r. 216-225 |
| HA151-5M | Tau Antibody | Capture-CLIA | Mouse Antibody, phosphorylated Tau, a.a.r. 181 |
| HP151-1 | Tau Antigen | Quality Control-CLIA | E.coli |
